Graham A. Showell
Merck Sharp & Dohme Federal Credit Union
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Graham A. Showell.
Bioorganic & Medicinal Chemistry | 1998
Graham A. Showell; Frances Emms; Rosemarie Marwood; Desmond O'Connor; Smita Patel; Paul D. Leeson
The synthesis of a series of 2,4-disubstituted morpholines is described and their affinities at human dopamine receptors reported. The orally bioavailable 7-azaindole compound 11 has nanomolar affinity at the hD4 receptor with > 1000-fold selectivity over the hD2 receptor.
Bioorganic & Medicinal Chemistry | 2015
Raquel Ortega; Jorge Sanchez-Quesada; Christoph Lorenz; Grzegorg Dolega; Anna Karawajczyk; Miguel Sanz; Graham A. Showell; Fabrizio Giordanetto
The introduction of silicon in biologically-relevant molecules represents an interesting medicinal chemistry tactic. Its use is mainly confined to the fine-tuning of specific molecular properties and organosilicon compounds are underrepresented in typical screening libraries. As part of the European Lead Factory efforts to generate novel, drug discovery-relevant chemical matter, the design and synthesis of 1,1-disubstituted-1-silacycloalkane-based compound libraries is described.
Journal of The Chemical Society, Chemical Communications | 1988
John Saunders; Angus Murray Macleod; Kevin John Merchant; Graham A. Showell; Roger J. Snow; Leslie J. Street; Raymond Baker
The methyl ester functionality in arecoline and related esters has been replaced by 1,2,4-oxadiazole to generate the most potent and efficacious muscarinic agonists known.
Journal of The Chemical Society, Chemical Communications | 1992
Raymond Baker; Graham A. Showell; Leslie J. Street; John Saunders; Karst Hoogsteen; Stephen Freedman; Richard Hargreaves
The cyclopropyloxadiazole derivative described in the title has been shown to be a functionally selective M1 partial agonist with antagonist properties in M2 and M3 muscarinic receptor assays; conformational studies indicate free rotation around the oxadiazole–azanorbornane bond, whilst X-ray studies reveal that the cyclopropyl group is in conjugation with the oxadiazole CN bond.
Journal of Medicinal Chemistry | 1990
Leslie Joseph Harlow Street; Baker R; Tracey Book; Clare O. Kneen; Angus Murray Macleod; Kevin John Merchant; Graham A. Showell; John Saunders; Richard H. Herbert
Journal of Medicinal Chemistry | 1983
John Morris Evans; Charles S. Fake; Thomas C. Hamilton; Robert H. Poyser; Graham A. Showell
Journal of Medicinal Chemistry | 1994
Graham A. Showell; Sylvie Bourrain; Joseph George Neduvelil; Stephen Robert Fletcher; Raymond Baker; Alan P. Watt; Alan E. Fletcher; Stephen Freedman; John A. Kemp
Journal of Medicinal Chemistry | 1991
Graham A. Showell; Tracey L. Gibbons; Clare O. Kneen; Angus Murray Macleod; Kevin John Merchant; John Saunders; Stephen B. Freedman; Shailendra Patel; Baker R
Journal of Medicinal Chemistry | 1988
Paul D. Leeson; David Ellis; John Colin Emmett; Virendra P. Shah; Graham A. Showell; Anthony H. Underwood
Journal of Medicinal Chemistry | 1989
Paul D. Leeson; John Colin Emmett; Virendra P. Shah; Graham A. Showell; Ricardo Novelli; H. Douglas Prain; Martin G. Benson; David Ellis; Nigel J. Pearce; Anthony H. Underwood